%D8%AF%D9%88%D8%B1%D8%B2%D9%88%D9%84%D8%A7%D9%85%D9%8A%D8%AF%D8%AF%D9%88%D8%B1%D8%B2%D9%84%D8%A7%D9%85%DB%8C%D8%AFCategory:DorzolamideDorsolamidDorzolamidDorzolamideDorzolamida%D8%AF%D9%88%D8%B1%D8%B2%D9%84%D8%A7%D9%85%DB%8C%D8%AFDorzolamide%E3%83%89%E3%83%AB%E3%82%BE%E3%83%A9%E3%83%9F%E3%83%89Dorzolamid%D0%94%D0%BE%D1%80%D0%B7%D0%BE%D0%BB%D0%B0%D0%BC%D0%B8%D0%B4DorzolamidDorzolamidDorzolamideQ415401
about
P3781
MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)Patient Preference Comparison of AZARGA Versus COSOPT in Patients With GlaucomaEarlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for GlaucomaComparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)Efficacy and Safety of Topically Applied Medical Therapy for the Treatment of Pediatric GlaucomaPatient Preference Comparison of AZARGA Versus COSOPTComparing Effects of Two Fixed Combinations Ophthalmic Solutions on Ocular Blood FlowComparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension (2005-05-31)
P4844
Carbonic anhydrase inhibitors: topical sulfonamide antiglaucoma agents incorporating secondary amine moietiesCarbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties.Carbonic anhydrase inhibitors: 4-sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl-benzenecarboxamides with strong topical antiglaucoma properties.Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties.Carbonic anhydrase inhibitors: topically acting antiglaucoma sulfonamides incorporating esters and amides of 3- and 4-carboxybenzolamide.Carbonic anhydrase inhibitors: N-(p-sulfamoylphenyl)-alpha-D-glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits.Intrafamilial Phenotype Variability in Two Male Siblings, With X-linked Juvenile Retinoschisis and Dorzolamide Treatment Effect in the Natural History of the Disease
P921
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Dorzolamid
@de
Dorzolamid
@sh
Dorzolamid
@sr
Dorzolamida
@es
Dorzolamide
@it
Dorzolamide
@nl
Dorzolamide
@vi
dorsolamid
@cy
dorzolamid
@nn
dorzolamid
@pl
type
label
Dorzolamid
@de
Dorzolamid
@sh
Dorzolamid
@sr
Dorzolamida
@es
Dorzolamide
@it
Dorzolamide
@nl
Dorzolamide
@vi
dorsolamid
@cy
dorzolamid
@nn
dorzolamid
@pl
altLabel
(4S,6S)-4-Ethylamino-6-methyl- ...... hiopyran-2-sulfonic acid amide
@en
(4S,6S)-4-ethylamino-6-methyl- ...... hiopyran-2-sulfonic acid amide
@cy
(4S,6S)-4-ethylamino-6-methyl- ...... hiopyran-2-sulfonic acid amide
@en
(4S,trans)-4-(Ethylamino)-6-me ...... yran-2-sulfonamide 7,7-dioxide
@en
(4S,trans)-4-(ethylamino)-6-me ...... yran-2-sulfonamide 7,7-dioxide
@cy
(4S,trans)-4-(ethylamino)-6-me ...... yran-2-sulfonamide 7,7-dioxide
@en
(4S-trans)-4-(ETHYLAMINO)-5,6- ...... yran-2-sulfonamide-7,7-dioxide
@en
4-Ethylamino-6-methyl-7,7-diox ...... hiopyran-2-sulfonic acid amide
@en
4-Ethylamino-6-methyl-7,7-diox ...... hiopyran-2-sulfonic acid amide
@en
4S,6S-Dorzolamide
@en
prefLabel
Dorzolamid
@de
Dorzolamid
@sh
Dorzolamid
@sr
Dorzolamida
@es
Dorzolamide
@it
Dorzolamide
@nl
Dorzolamide
@vi
dorsolamid
@cy
dorzolamid
@nn
dorzolamid
@pl